Showing results (21-30 of 283) with videos related to
Sort By:
Pageof 29
Seminars in Thrombosis and Hemostasis|October 23, 2012
Underreporting of hemorrhagic and thrombotic complications of pharmaceuticals to the U.S. Food and Drug Administration: empirical findings for warfarin, clopidogrel, ticlopidine, and thalidomide from the Southern Network on Adverse Reactions (SONAR)Thomas J Moore, Charles L BennettCancer|December 13, 2005
Local perspective of the impact of the HIPAA privacy rule on researchMichael S Wolf, Charles L BennettDrugs & Aging|May 17, 2003
Cost analyses of adjunct colony stimulating factors for older patients with acute myeloid leukaemia : can they improve clinical decision making?Charles L Bennett, Glen T SchumockJournal of Nephrology|September 21, 2013
Forewarned is forearmed: erythropoietin use in CKD patients with cancerSamuel J Kessler, Charles L BennettSeminars in Oncology|February 19, 2005
Pharmacoeconomics of liposomal anthracycline therapyCharles L Bennett, Elizabeth A CalhounThe Oncologist|May 2, 2007
Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patientsCharles L Bennett, Elizabeth A CalhounSeminars in Oncology|November 9, 2019
Reflections on and future of hematologic malignancies research in the Veterans Health AdministrationDaphne R Friedman, Kenneth R Carson, J Brice WeinbergJournal of Evaluation in Clinical Practice|April 24, 2019
Failure to place evidence at the centre of quality improvement remains a major barrier for advances in quality improvementBenjamin Djulbegovic, Charles L Bennett, Gordon GuyattCancer Treatment and Research|November 30, 2022
Policing of Drug Safety Information Dissemination Under the False Claims ActBrian Chen, Tony Yang, Charles L BennettJournal of Evaluation in Clinical Practice|November 22, 2018
A unifying framework for improving health careBenjamin Djulbegovic, Charles L Bennett, Gordon GuyattPageof 29